Oakbrook Investments Lowered Its Position in United Technologies Corporatio (UTX) by $3.44 Million as Share Price Rose; Hamilton Lane Advisors Has Upped Its Stake in Clovis Oncology (CLVS) by $666,810

November 15, 2017 - By Hazel Jackson

Oakbrook Investments Llc decreased its stake in United Technologies Corporatio (UTX) by 43.85% based on its latest 2017Q2 regulatory filing with the SEC. Oakbrook Investments Llc sold 28,200 shares as the company’s stock rose 8.03% with the market. The institutional investor held 36,113 shares of the aerospace company at the end of 2017Q2, valued at $4.41M, down from 64,313 at the end of the previous reported quarter. Oakbrook Investments Llc who had been investing in United Technologies Corporatio for a number of months, seems to be less bullish one the $94.87 billion market cap company. The stock declined 0.47% or $0.56 reaching $118.24 per share. About 18,866 shares traded. United Technologies Corporation (NYSE:UTX) has risen 22.99% since November 15, 2016 and is uptrending. It has outperformed by 6.29% the S&P500.

Hamilton Lane Advisors Llc increased its stake in Clovis Oncology Inc. (CLVS) by 201.74% based on its latest 2017Q2 regulatory filing with the SEC. Hamilton Lane Advisors Llc bought 7,170 shares as the company’s stock declined 20.61% while stock markets rallied. The institutional investor held 10,724 shares of the health care company at the end of 2017Q2, valued at $1.00M, up from 3,554 at the end of the previous reported quarter. Hamilton Lane Advisors Llc who had been investing in Clovis Oncology Inc. for a number of months, seems to be bullish on the $3.21 billion market cap company. The stock declined 0.31% or $0.2 reaching $65.29 on the news. About 200 shares traded. Clovis Oncology Inc (NASDAQ:CLVS) has risen 282.71% since November 15, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

Oakbrook Investments Llc, which manages about $3.64 billion and $1.51 billion US Long portfolio, upped its stake in Equifax Inc. (NYSE:EFX) by 3,280 shares to 7,980 shares, valued at $1.10 million in 2017Q2, according to the filing. It also increased its holding in The Kraft Heinz Company by 26,450 shares in the quarter, for a total of 28,850 shares, and has risen its stake in Philip Morris International (NYSE:PM).

Analysts await United Technologies Corporation (NYSE:UTX) to report earnings on January, 24. They expect $1.56 earnings per share, 0.00% or $0.00 from last year’s $1.56 per share. UTX’s profit will be $1.25 billion for 18.95 P/E if the $1.56 EPS becomes a reality. After $1.73 actual earnings per share reported by United Technologies Corporation for the previous quarter, Wall Street now forecasts -9.83% negative EPS growth.

Among 21 analysts covering United Technologies Corporation (NYSE:UTX), 6 have Buy rating, 0 Sell and 15 Hold. Therefore 29% are positive. United Technologies Corporation had 66 analyst reports since July 21, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of UTX in report on Monday, August 7 with “Buy” rating. The firm has “Buy” rating given on Wednesday, July 22 by Argus Research. RBC Capital Markets maintained it with “Hold” rating and $125.0 target in Friday, September 15 report. The firm earned “Neutral” rating on Monday, October 10 by Citigroup. RBC Capital Markets downgraded the shares of UTX in report on Tuesday, October 13 to “Sector Perform” rating. The rating was maintained by Jefferies with “Buy” on Monday, August 28. Bernstein downgraded the shares of UTX in report on Friday, January 8 to “Mkt Perform” rating. The rating was maintained by Cowen & Co on Tuesday, July 25 with “Buy”. The firm earned “Hold” rating on Wednesday, September 6 by Deutsche Bank. Goldman Sachs downgraded the shares of UTX in report on Monday, May 2 to “Neutral” rating.

More notable recent United Technologies Corporation (NYSE:UTX) news were published by: Nasdaq.com which released: “United Technologies (UTX) Beats on Q3 Earnings & Revenues” on October 24, 2017, also Seekingalpha.com with their article: “United Technologies: Selling Sikorsky And Buying Rockwell Collins: 2 Great …” published on October 26, 2017, Nasdaq.com published: “Low Revenues to Hurt United Technologies (UTX) Q3 Earnings?” on October 20, 2017. More interesting news about United Technologies Corporation (NYSE:UTX) were released by: Nasdaq.com and their article: “United Technologies Corporation (UTX) Ex-Dividend Date Scheduled for November …” published on November 15, 2017 as well as Wsj.com‘s news article titled: “United Technologies’ Profit Falls Amid Jet-Engine Production Problems” with publication date: October 24, 2017.

Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.03, from 0.98 in 2017Q1. It worsened, as 39 investors sold UTX shares while 553 reduced holdings. 112 funds opened positions while 451 raised stakes. 611.76 million shares or 0.92% less from 617.43 million shares in 2017Q1 were reported. Regent Invest Mngmt Limited Liability Com has 7,355 shares for 0.32% of their portfolio. The Pennsylvania-based Pitcairn has invested 0.2% in United Technologies Corporation (NYSE:UTX). Farr Miller Washington Lc Dc has 2.55% invested in United Technologies Corporation (NYSE:UTX) for 213,683 shares. Ledyard Bancshares holds 0.44% in United Technologies Corporation (NYSE:UTX) or 25,390 shares. Segall Bryant & Hamill Limited Liability Corp holds 24,433 shares or 0.07% of its portfolio. Gamco Invsts Incorporated Et Al owns 14,316 shares for 0.01% of their portfolio. Advantus Cap Mgmt owns 75,198 shares for 0.24% of their portfolio. 51,341 are owned by Eagle Ridge Invest. Fayerweather Charles invested in 2.86% or 17,372 shares. Mackay Shields Limited Liability Com owns 0.27% invested in United Technologies Corporation (NYSE:UTX) for 53,105 shares. City Co, West Virginia-based fund reported 25,505 shares. Davis Selected Advisers reported 7.77 million shares or 4.15% of all its holdings. Monarch Mngmt invested in 2.14% or 46,380 shares. Btim Corporation has 15,231 shares. Nelson Roberts Investment Advisors Limited Company, California-based fund reported 42,800 shares.

More recent Clovis Oncology Inc (NASDAQ:CLVS) news were published by: Businesswire.com which released: “Clovis Oncology Announces Third Quarter 2017 Operating Results” on November 01, 2017. Also Businesswire.com published the news titled: “Clovis Oncology to Present at the Stifel 2017 Healthcare Conference” on November 08, 2017. Bizwest.com‘s news article titled: “Clovis Oncology misses on earnings, revenue” with publication date: November 02, 2017 was also an interesting one.

Since June 15, 2017, it had 0 insider purchases, and 1 sale for $185,460 activity.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 70% are positive. Clovis Oncology had 53 analyst reports since September 10, 2015 according to SRatingsIntel. The stock of Clovis Oncology Inc (NASDAQ:CLVS) has “Buy” rating given on Wednesday, August 24 by Suntrust Robinson. The stock of Clovis Oncology Inc (NASDAQ:CLVS) has “Buy” rating given on Friday, August 5 by Suntrust Robinson. The stock of Clovis Oncology Inc (NASDAQ:CLVS) earned “Buy” rating by Bank of America on Friday, January 27. The firm earned “Buy” rating on Tuesday, July 18 by Credit Suisse. The stock of Clovis Oncology Inc (NASDAQ:CLVS) earned “Outperform” rating by Credit Suisse on Wednesday, September 21. Chardan Capital Markets upgraded Clovis Oncology Inc (NASDAQ:CLVS) on Monday, June 19 to “Neutral” rating. The firm earned “Buy” rating on Wednesday, August 24 by SunTrust. The company was maintained on Wednesday, September 6 by J.P. Morgan. The firm has “Neutral” rating given on Tuesday, December 20 by Chardan Capital Markets. The firm has “Outperform” rating by Credit Suisse given on Thursday, January 21.

Investors sentiment decreased to 1.81 in 2017 Q2. Its down 0.66, from 2.47 in 2017Q1. It is negative, as 33 investors sold CLVS shares while 56 reduced holdings. 74 funds opened positions while 87 raised stakes. 46.46 million shares or 12.58% more from 41.27 million shares in 2017Q1 were reported. Clarivest Asset Management Ltd Limited Liability Company has 14,785 shares. Hbk Invs Lp owns 125,406 shares. State Street Corp owns 1.94M shares. Frontier Lc has 0.06% invested in Clovis Oncology Inc (NASDAQ:CLVS). 6,141 were reported by Marshall Wace Llp. Franklin Resources Inc has 0.08% invested in Clovis Oncology Inc (NASDAQ:CLVS) for 1.67M shares. Point72 Asset Mngmt Limited Partnership holds 0.02% or 30,000 shares. Rice Hall James Limited Liability Corp invested in 126,413 shares. Jennison Associate Ltd Liability Company reported 0.12% in Clovis Oncology Inc (NASDAQ:CLVS). Bnp Paribas Asset Mgmt Holdg Sa holds 0.04% in Clovis Oncology Inc (NASDAQ:CLVS) or 44,502 shares. Guggenheim Ltd Liability Co invested in 0.01% or 55,002 shares. Great West Life Assurance Can holds 0% or 4,293 shares in its portfolio. Kbc Gp Nv reported 54,089 shares. Advent Capital De owns 18,750 shares or 0.03% of their US portfolio. Samlyn has invested 1.3% in Clovis Oncology Inc (NASDAQ:CLVS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com